GSK gets FDA approval for Benlysta to treat active lupus nephritis in children
Benlysta was previously approved in the US to treat active lupus nephritis in adult patients, and the current…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Jul 22
Benlysta was previously approved in the US to treat active lupus nephritis in adult patients, and the current…
27 Jul 22
The EC approved Rinvoq based on positive data from induction studies, U-ACHIEVE induction and U-ACCOMPLISH, and a maintenance…
27 Jul 22
The expanded approval for Nuvaxovid in Japan and Australia is supported by positive safety, immunogenicity, and efficacy data…
26 Jul 22
In addition, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has separately recommended…
25 Jul 22
Based on the CHMP recommendation, the European Commission (EC) will grant the final approval soon, which will be…
22 Jul 22
CMA concluded that the companies exploited their dominant market position to inflate the final price for the key…
21 Jul 22
The EC authorisation follows the positive recommendation by European Medicines Agency (EMA) Committee for Medicinal Products for Human…
21 Jul 22
Biogen was alleged of paying kickbacks to health care professionals to discourage them from prescribing products of its…
18 Jul 22
The EC granted conditional marketing authorisation for Kinpeygo based on the efficacy and safety data from Part A…
14 Jul 22
The US FDA granted the EUA based on data from the Phase 3 PREVENT-19 clinical trial, in which…